Althea CBD100 Oral Oil — Buy Online – Althea CBD100 Oral Oil
Althea CBD100 Oral Oil High-Capacity Premium
The Althea CBD100 Oral Oil High-Capacity Premium occupies the upper tier of pharmaceutical-grade cannabidiol oral preparations available through Australia’s Therapeutic Goods Administration approved medicinal cannabis supply chain. Althea is one of Australia’s most recognised and longest-standing licensed medicinal cannabis companies, and the CBD100 formulation represents their commitment to delivering a high-concentration cannabidiol product that meets the exacting expectations of patients, prescribing practitioners, and pharmacists operating within a regulated clinical environment. Every bottle that reaches a patient has passed through a documented manufacturing, testing, and dispensing process that distinguishes it categorically from unregulated wellness supplements.
The decision to formulate at 100 milligrams of cannabidiol per millilitre reflects a clinical understanding that patients requiring meaningful therapeutic support often need higher concentration preparations to achieve their prescribed daily dose in a manageable oil volume. Patients working with lower-concentration oils frequently experience dosing inconvenience, larger required volumes, and greater variability in daily intake. The Althea CBD100 Oral Oil resolves these practical challenges by delivering more active compound per drop, making precise titration easier to manage and daily compliance more straightforward for patients across a range of treatment contexts.
Althea operates under an Office of Drug Control licence in Australia and manufactures to Good Manufacturing Practice standards, which means every stage of production from raw material intake through to finished product release is subject to documented quality controls. This regulatory foundation is not incidental to the product. It is the product. When a patient selects the Althea CBD100 Oral Oil High-Capacity Premium, they are selecting a formulation whose quality is enforced by a licensed regulatory framework, not merely claimed by a marketing department.

Condition Metrics and Product Specifications
THC Percentage: The Althea CBD100 Oral Oil is formulated as a Schedule 4 cannabidiol preparation under Australian scheduling regulations, meaning the THC content is present at trace levels only and falls within the limits defined by the TGA for CBD-predominant medicinal cannabis products. The formulation is not designed to produce psychoactive effects, and prescribing practitioners recommend it within that clinical context.
CBD Percentage: Each millilitre of this oral oil contains 100 milligrams of cannabidiol, making it one of the highest per-millilitre CBD concentrations available in the Australian regulated medicinal cannabis market. At this concentration, patients prescribed a daily dose of 25 to 50 milligrams require only a small measured volume, supporting accurate and consistent administration.
Terpene Profile: As a pharmaceutical-grade oral oil, the Althea CBD100 formulation is produced to a defined and consistent cannabinoid specification. Any residual terpene content reflects the natural profile of the source cultivar material carried through the extraction process. Patients seeking a specific terpene-rich broad-spectrum experience should discuss this with their prescribing practitioner, as Althea offers a range of formulations across different profiles.
Cultivar Lineage: Althea sources its cannabidiol from cultivars selected for their cannabinoid expression profile and suitability for pharmaceutical extraction processes. The cultivar selection prioritises consistent CBD yield, low THC expression, and chemical stability through extraction, which underpins the reproducibility that a 100mg per millilitre concentration specification demands.
Batch Testing: Every batch of Althea CBD100 Oral Oil is tested by a TGA-compliant analytical laboratory covering cannabinoid potency, residual solvent levels, pesticide residue, heavy metals, and microbial contamination. Certificates of analysis are generated per batch and are available to prescribing practitioners and dispensing pharmacists through Althea’s standard documentation channels.
Moisture Content: The oil carrier formulation is selected and controlled for water activity to ensure product stability and shelf life integrity. The oral oil format inherently limits moisture-related degradation risks compared to dried flower products, and the formulation stability is verified through shelf-life testing conducted under the product’s approved storage conditions.
Trim Quality: This specification applies to the upstream botanical material used in extraction. Althea applies quality intake standards to all incoming plant material used in their manufacturing process, ensuring that the source material meets defined quality thresholds before entering the extraction stage. The result is a finished oil whose quality reflects deliberate upstream control, not variable raw material.

Packaging Freshness Seal: Each bottle of Althea CBD100 Oral Oil is sealed with a tamper-evident closure that provides visible confirmation of product integrity from the point of manufacture through to patient receipt. The bottle is amber glass to protect the oil from light degradation, and secondary packaging provides an additional barrier. Patients should inspect the seal on receipt and contact their dispensing pharmacy if any sign of tampering is present.
Secure Dispensing Logistics and Our Fulfillment Guarantee
All orders for Althea CBD100 Oral Oil placed through this store are processed in compliance with the dispensing requirements applicable to Schedule 4 medicinal cannabis products in Australia. Prescription verification is completed before any order is prepared for dispatch, and no product leaves our facility without that verification step being fully documented. This is not a procedural formality. It is a patient safety requirement that we apply without exception on every single order regardless of order history or repeat patient status.
Shipment is conducted via a tracked and insured freight service appropriate for regulated pharmaceutical products. Full declared value insurance is applied to every shipment, and delivery is completed on a signature-required basis to ensure the product reaches the authorised recipient and does not sit unattended at a delivery address. Cold chain considerations are observed where required by the product’s approved storage conditions, and packaging is selected to maintain product integrity across the expected transit time and temperature range.
In the event that a shipment arrives with evidence of damage or packaging compromise, our damage claim process is initiated within twenty-four hours of patient notification. We retain all dispatch documentation, packing records, and carrier booking information needed to support a complete and timely resolution. Our commitment to patients extends past the point of dispatch, and we do not consider an order fulfilled until the product is in your hands in perfect condition. Patients looking to explore the full range of medicinal cannabis formulations available through this store are invited to browse the complete concentrates, extracts, inhalation, and ingestion collection at https://littlegreenpharma.shop/product-category/concentrates-extracts-inhalation-ingestion/ where additional oral oils, capsules, and inhalation products are listed.
TGA-compliant analytical laboratory
Frequently Asked Questions













Reviews
There are no reviews yet.